Penn Capital Management Company, LLC Codex Dna, Inc. Transaction History

Penn Capital Management Company, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	N/A	28,870 Added 4.98%	608,392 $1.13 Million
Q2 2023 Aug 14, 2023	BUY	N/A	35,239 Added 6.47%	579,522 $1.07 Million
Q1 2023 May 15, 2023	BUY	$1.3 - $2.15 $707,567 - $1.17 Million	544,283 New	544,283 $1.01 Million
Q4 2022 Feb 13, 2023	BUY	$1.12 - $1.69 $230,723 - $348,145	206,003 Added 21.28%	1,174,062 $1.47 Million
Q3 2022 Dec 09, 2022	BUY	$1.7 - $2.36 $1.65 Million - $2.28 Million	968,059 New	968,059 $1.61 Million
Q2 2022 Aug 15, 2022	BUY	$1.8 - $6.45 $943,959 - $3.38 Million	524,422 New	524,422 $944,000

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Penn Capital Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Penn Capital Management Company, LLC with notifications on news.